Cover Image
市場調查報告書

糖尿病神經病變的疼痛:全球臨床實驗檢討

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 306663
出版日期 內容資訊 英文 88 Pages
訂單完成後即時交付
價格
Back to Top
糖尿病神經病變的疼痛:全球臨床實驗檢討 Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2016
出版日期: 2016年06月30日 內容資訊: 英文 88 Pages
簡介

本報告提供糖尿病神經病變的疼痛相關的臨床研究最新趨勢分析,為您彙整疾病治療方法概要,及臨床實驗的主要國家──G7各國及E7(新興7國)的臨床實驗數及實驗對象採用狀況,地區、Phase、階段別的進展,有潛力的贊助商,各企業研究機關的研究進展,有潛力的藥劑比較等資訊。

目錄

簡介

  • 糖尿病神經病變的疼痛
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 的臨床實驗數量亞太地區的主要5個國家
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東及非洲主要國家的臨床實驗數量
    • 的臨床實驗數量中南美的主要5個國家

G7各國臨床實驗數量:中樞神經系統疾病臨床實驗數量中,糖尿病神經病變的疼痛臨床實驗數量比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7(新興7個國家)各國臨床實驗數量:中樞神經系統疾病臨床實驗數量中,糖尿病神經病變的疼痛臨床實驗數量比例

E7(新興7個國家)各國臨床實驗數量:Phase別

E7(新興7個國家)各國臨床實驗數量:各進展狀況

Phase別臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

尚未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Pfizer Inc.
    • Eli Lilly and Company
    • AbbVie Inc.
    • Grunenthal GmbH
    • Swedish Orphan Biovitrum AB
    • E. Merck KG
    • Dong-A Socio Holdings Co Ltd
    • 第一三共
    • BioDelivery Sciences International, Inc.
    • AstraZeneca PLC
  • 有代表性的研究機關·醫院臨床實驗概要
    • Kermanshah University of Medical Sciences
    • Taipei Medical University Hospital
    • St Vincents University Hospital
    • Irmandade da Santa Casa de Misericordia de Sao Paul
    • Center for Medicinal Cannabis Research
    • China Medical University Hospital
    • Albany Medical Center
    • Shiraz University of Medical Sciences
    • Leiden University Medical Center
    • Weill Cornell Medical College

5個有代表性的臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3527CTIDB

GlobalData's clinical trial report, "Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Neuropathic Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Diabetic Neuropathic Pain Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Region, 2016*
  • Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016*
  • Diabetic Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Diabetic Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016*
  • Diabetic Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Diabetic Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Diabetic Neuropathic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016*
  • Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016*
  • Diabetic Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Diabetic Neuropathic Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Diabetic Neuropathic Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016*
  • Diabetic Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Diabetic Neuropathic Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Diabetic Neuropathic Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Diabetic Neuropathic Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Diabetic Neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top